Ascent Pharmahealth Report issue

For profit Phase 1
Founded: Melbourne Australia (2003)
Status: Acquired by Watson Pharmaceuticals (2012) → now AbbVie (2019)

Organization Overview

First Clinical Trial
2013
NCT03832426
First Marketed Drug
2003
lisinopril (zestril)
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Ascent | Ascent Pediatrics | ASCENT PHARMS INC